ArticleThe Korean journal of internal medicine2020

Renal safety and urate-lowering efficacy of febuxostat in gout patients with stage 4-5 chronic kidney disease not yet on dialysis.

Sang-Hyon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.